tiprankstipranks
Avecho Biotechnology Limited (AU:AVE)
ASX:AVE
Holding AU:AVE?
Track your performance easily

Avecho Biotechnology Limited (AVE) Financial Statements

3 Followers

Avecho Biotechnology Limited Financial Overview

Avecho Biotechnology Limited's market cap is currently ―. The company's EPS TTM is AU$-0.001; its P/E ratio is -9.09; Avecho Biotechnology Limited is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 1.47MAU$ 3.26MAU$ 1.87MAU$ 3.21MAU$ 2.11M
Total AssetsAU$ 3.35MAU$ 5.25MAU$ 3.35MAU$ 5.32MAU$ 4.80M
Total DebtAU$ 246.07KAU$ 93.91KAU$ 166.23KAU$ 97.19KAU$ 0.00
Net DebtAU$ -1.22MAU$ -3.17MAU$ -1.71MAU$ -3.11MAU$ -2.11M
Total LiabilitiesAU$ 920.66KAU$ 709.36KAU$ 700.17KAU$ 556.13KAU$ 902.04K
Stockholders EquityAU$ 2.42MAU$ 4.54MAU$ 2.65MAU$ 4.76MAU$ 3.90M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Avecho Biotechnology Limited Earnings and Revenue History

Avecho Biotechnology Limited Debt to Assets

Avecho Biotechnology Limited Cash Flow

Avecho Biotechnology Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis